Neogen Corp. Aktie
Kurs
Kursziel
11,10 €
11,10 €
-8,26 %
-1,0
-8,26 %
20,08 €
16.04.24 / Frankfurt
WKN: 883297 / Symbol: NEOG / Name: Neogen / Aktie / Ausrüstung & Versorgung / Mid Cap /
Gib deine Einschätzung ab, um die Meinung der Community zu sehen!
sharewise basiert auf der Weisheit der Vielen. Diese funktioniert am Besten, wenn man nicht durch die Einschätzungen der anderen Mitglieder beeinflusst ist. Bitte klicke einen Button an, dann siehst Du sofort, wie die Community abgestimmt hat.
Deine Einschätzung
Neogen Corp. Aktie
Die Neogen Corp. Aktie erleidet heute einen großen Rückgang von -8,26 %.
Die Community ist unsicher über Neogen Corp.: Zu wenige Buy- und Sell-Einschätzungen vorhanden.
Das von der Community festgelegte Kursziel von 20 € für Neogen Corp. bedeutet eine mögliche Steigerung um über 50% im Vergleich zu 11.1 €.
Die Community zeigt eine positive Haltung zur Neogen Corp. Aktie, wobei das Kriterium Lohnenswerte Investition für die nächsten Jahre als Hauptstärke gilt.
Was spricht für und gegen Neogen Corp. in den nächsten Jahren?
Pro
?
M****
?
U****************
?
W******* i* V********
Kontra
?
M************
?
A****************
?
L*********** I********** f** d** n******* J****
Sag auch du uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Neogen Corp. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Neogen Corp. | -8,26 % | -5,93 % | -19,57 % | -23,45 % | -39,34 % | -71,54 % | -55,53 % |
Merit Medical Systems | 1,49 % | 2,26 % | 3,82 % | -2,16 % | 0,00 % | 34,65 % | 25,67 % |
Bio-Rad Labs Inc. A | -0,22 % | -11,52 % | -11,09 % | -38,16 % | -7,15 % | -48,08 % | - |
Haemonetics Corp. | - | -1,26 % | 15,44 % | 3,29 % | 1,95 % | -20,30 % | 6,48 % |
Kommentare
SecteurEquipement, fournitures et distribution médicale Agenda 26/03 Publication de résultats
Manufactures and markets medical testing kits
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety.
It operates through the following segments: Food Safety, Animal Safety, and Corporate.
The Food Safety segment consists of the development, production and marketing of diagnostic test kits, dehydrated culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation.
The Animal Safety segment includes the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors.
The Corporate segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments.
The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety.
It operates through the following segments: Food Safety, Animal Safety, and Corporate.
The Food Safety segment consists of the development, production and marketing of diagnostic test kits, dehydrated culture media and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation.
The Animal Safety segment includes the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors.
The Corporate segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments.
The company was founded on June 30, 1981 and is headquartered in Lansing, MI.
Nombre d'employés : 1 546 personnes.